Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), sold 5,000 shares at $161.36 ($807K) on 2015-03-05, disclosed to the SEC on 2015-03-06.
Scheduled sale ($807k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |